Please login to the form below
evolucumab
This page shows the latest evolucumab news and features for those working in and with pharma, biotech and healthcare.
Amgen's Repatha unclogs blocked arteries, says study
Looks to boost sales after trial shows clear clinical advantage of PCSK9 inhibitor over statins
Latest news
-
SMC rejects Amgen's Repatha over lack of outcomes data
The Scottish Medicines Consortium (SMC) has turned down Amgen's cholesterol-lowering treatment Repatha (evolucumab), citing a lack of “ robust” data.
-
NICE persuaded to back Praluent as well as Repatha
drug. The scheme includes an undisclosed discount to the NHS and allows NICE to back Praluent and Amgen's rival Repatha (evolucumab), which had already agreed a price cut, in new
More from news
Approximately 3 fully matching, plus 0 partially matching documents found.
Featured jobs
- Senior Account Managers - Oxfordshire
-
Attractive salary and benefits package offered
- Scientific Director / Editorial Team Leader
-
Great salary and benefits
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Consumer Health Account Director
-
Circa £60, 000 Gym and More
- Digital Manager, London – Healthcare Brandcomms, Medcomms, PR
-
Excellent package
-
Associate Medical Director
-
Highly Competitive
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
-
Account Director
-
Excellent benefits
-
Medical/ Scientific Director
-
Salary TBC
- Senior Account Executive, London, Medical Communications
-
Excellent package
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Senior Medical Writer
-
Great salary and benefits
- Director, Market Access / HEOR - North-West
-
Negotiable
- Events Manager – Med Comms – Surrey
-
Salary TBC
Subscribe to our email news alerts
- Golin opens office in Malaysia
- Synergy Vision to introduce four-day working week
- SWITCHED ONcology. Caregivers Focus Group Highlights. www.switchedoncology.com
- World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
- Life Sciences 4.0 - Antony Rawlins
- What is blockchain? - Richard Springham
Latest intelligence
- World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
- Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
- World Diabetes Day: Interaction and impact of diabetes on mental health
- For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
- Innovation in merger control and the impact on the pharmaceutical sector
- Is focusing on pipeline products enough to assess regulatory risks?...
Quick links
Infographics
